AstraZeneca today announced the completion of the licensing agreement between MedImmune, its global biologics research and development arm, and Allergan plc, for the global rights to MEDI2070.
MEDI2070 is an IL-23 monoclonal antibody currently in a Phase IIb clinical trial for moderate-to-severe Crohn’s disease and ready for Phase II for ulcerative colitis, diseases that sit outside AstraZeneca’s three main therapy areas.
Calling all innovators, startups, and entrepreneurs: join us in participating in the first-ever #FosterlyCensus — a region-wide, community project gathering information and statistics about our rapidly expanding ecosystem. Be a part of the most comprehensive, resourceful survey our city has ever seen by filling out the info at http://fosterly.com.
California, the nation’s birthplace of biotechnology, continues to add jobs in that sector and the life sciences in general, a trade association reported Wednesday.
While growth is slow, the life sciences remain a potent economic force, especially in San Diego County and the San Francisco Bay area. There are also signs of expansion in Los Angeles County, which has long been overshadowed by its neighbors to the north and south.
International Trade – The Basics for Bio & Technology Companies
Attend this lunch-and-learn event to hear global industry experts discuss how Maryland companies can leverage resources to fund and market their international ambitions. Hear from one local company who has successfully taken advantage of these tools. WHO SHOULD ATTEND: Existing companies and startups in the life sciences and health technology industries
Integrated BioTherapeutics (IBT) announced today that it has entered into an exclusive worldwide license agreement with Emergent BioSolutions Inc. (NYSE: EBS) whereby Emergent will gain exclusive rights to use IBT’s proprietary vaccine antigens and know-how in a joint research, development, and manufacturing collaboration focused on an equine-based hyperimmunoglobulin for the treatment of hemorrhagic fever caused by Filoviruses. Financial terms of the agreement are not disclosed.
OCTOBER 27, 2015 @ 8:00 AM – OCTOBER 29, 2015 @ 5:00 PM
Join us for the 17th Annual National Institutes of Health Small Business Innovation Research & Small Business Technology Transfer Conference. This year’s conference From Washington to Washington: Supporting Small Business Innovation for Health, will provide attendees an opportunity to learn more about the $780 million in annual NIH funding available exclusively for small businesses to perform innovative research and build new businesses based on their technologies.
A Chinese group has become the first to inject a person with cells that contain genes edited using the revolutionary CRISPR–Cas9 technique.
On 28 October, a team led by oncologist Lu You at Sichuan University in Chengdu delivered the modified cells into a patient with aggressive lung cancer as part of a clinical trial at the West China Hospital, also in Chengdu.
As the IoT reels from and struggles with ongoing security issues stemming from DDoS and botnet and SSH and DNS and innumerable other interrelated problems, the industry needs outside input and leadership to give it strategic guidance.
According to a recent announcement, one such source of guidance will be in the form of the Rockville Innovation Center (RIC) in Montgomery County, Maryland, where BioHealth Innovation (BHI) has partnered with The MITRE Corporation, a not-for-profit corporation that operates federally funded research and development centers (FFRDCs), including the National Cybersecurity FFRDC, to look for innovative solutions to next-generation security threats.
A $25,000 contribution from AT&T will help the MdBio Foundation boost science, technology, engineering and math (STEM) education in Maryland. The contribution supports MdBio programs for underserved high school and rising middle school students, including the MdBioLab, a mobile laboratory that travels across the state giving students hands-on STEM experiences.
Brian Gaines, CEO of the MdBio Foundation, made the announcement during today’s Advancing Tomorrow’s Leaders in STEM (ATLAS) event at the University of Maryland BioPark in Baltimore. ATLAS is a college and career readiness symposium that offers students underrepresented in STEM an opportunity to connect with business leaders, colleges, government agencies and potential employers.
Roche has launched a global cancer immunotherapy Centers of Research Excellence network, saying it will invest up to 100 million Swiss francs ($100.3 million) in the project.
The research network of 21 academic centers around the world is intended to support basic and clinical research collaboration to advance the science of cancer immunotherapy, the Basel-based drugmaker said on Tuesday.
